Kennedy Investment Group Bristol Myers Squibb CO Transaction History

Kennedy Investment Group

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	BUY	$63.71 - $70.74 $1,210 - $1,344	19 Added 0.57%	3,338 $213 Million
Q1 2023 May 31, 2023	BUY	$65.71 - $74.53 $1,577 - $1,788	24 Added 0.73%	3,319 $230 Million
Q4 2022 May 31, 2023	BUY	$68.48 - $81.09 $225,641 - $267,191	3,295 New	3,295 $237 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kennedy Investment Group, based on Form 13F filings with the SEC.

Stay updated on Kennedy Investment Group with notifications on news.